Home Podcast Resolving LiveRamp’s Identity, With CEO Scott Howe

Resolving LiveRamp’s Identity, With CEO Scott Howe

SHARE:

You can subscribe to AdExchanger Talks on iTunes, Google Play, Spotify, Stitcher, SoundCloud or wherever you get your podcasts.

LiveRamp is by far the most widely used platform for first-party data onboarding and identity resolution. This week on the podcast, its gregarious CEO Scott Howe talks about the company’s wild ride – from private concern to Acxiom subsidiary to public company valued at $3 billion – and where it’s headed next.

According to Howe, LiveRamp’s real advantage, and its future opportunity, is all about the network effects.

“By virtue of connecting more and more constituents across the ecosystem, everybody benefits,” he says. “The bigger we get, the more value we provide to all of the constituents and the harder it is for anyone to replicate that value.”

For that reason, he says, “From the get-go we decided we were going to be neutral. We will license our capabilities to anyone and everyone who is ethical in the industry, including potential competitors. Many times when we go head to head with a potential competitor, we’re going to win either way.”

This consideration was a factor behind the 2018 sale of Acxiom to Interpublic Group. LiveRamp wanted to partner more closely with Acxiom competitors like Epsilon and Merkle, and being stand-alone let it do so.

Today, marketers are at a critical turning point when it comes to the use of data in marketing and the underpinnings of digital identity. Howe’s career has been largely focused on this issue (“My story is the story of data,” he says) and so he takes the long view. He observes data-driven personalization is not only about marketing, but also about healthcare, education, government services and other functions. It’s an unstoppable force.

“Data is not going anywhere. The utilization of data has been one of the greatest fuels of the economy that history has ever seen,” Howe says. “What we need are some guardrails.”

But there is a group that should be concerned, he adds. “Any publisher or app developer that relies on another party to do their authentication is in danger of being disintermediated.”

Tagged in:

Must Read

The Healthcare Marketing Tech Company OptimizeRx Is Going Programmatic

OptimizeRx, which has software that plugs into the systems doctors use to prescribe drugs and maintain patient records, has taken its next big step into the world of programmatic through a new partnership with The Trade Desk.

Single continuous line drawing robot riding pencil rocket flying in the sky. Tech education and creativity. Future technology development. Artificial intelligence. One line design vector illustration

Q3: Omnicom’s Media Business Is Growing, But Is It Agent-Proof?

If AI agents can plan and buy media, who needs a holding company? Good question. It came up during Omnicom’s Q3 earnings on Thursday.

Netflix Touts New Measurement Capabilities As It Struggles With “Modest” Engagement Growth

Netflix’s revenue grew 12% YOY to $12.9 billion in Q3, which it maintains is in line with its forecast. Its ads business, however, is lagging slightly compared with expectations, causing Netflix to tweak its forecast for the rest of the year.

Privacy! Commerce! Connected TV! Read all about it. Subscribe to AdExchanger Newsletters

Apple Publishes Its Plan To Wipe Out Web Tracking

Apple is coming for identity resolution. WebKit’s latest tracking crackdown targets the infrastructure behind post-cookie IDs – and switching to a first-party setup won’t necessarily spare vendors.

AI Slop Sites Are On The Rise. Is Ad Tech Ready For Its New MFA Challenge?

Advertising supply chain intelligence company DecryptAds uncovered more than 2,100 AI-generated recipe sites that are monetized with programmatic ads and feature fabricated author profiles.

How Australian Home Lender Lendi Measures The Invisible Work Of AI

Most brands and businesses are trying to figure out how to improve their metrics when it comes to AI – and also what those metrics even are.